Literature DB >> 22011209

Prevalence and temporal trends of hepatitis B, hepatitis C, and HIV/AIDS co-infection during pregnancy across the decade, 1998-2007.

Hamisu M Salihu1, Laura Connell, Jason L Salemi, Euna M August, Hanna E Weldeselasse, Amina P Alio.   

Abstract

BACKGROUND: Limited data are available on hepatitis rates during pregnancy by socio-demographic characteristics. This study examined temporal trends in hepatitis B virus (HBV) and hepatitis C virus (HCV) mono-infections and HIV/HBV and HIV/HCV co-infections in subpopulations among pregnant women in Florida between 1998 and 2007.
METHODS: We analyzed all Florida live births from 1998 to 2007 using hospital discharge data linked to birth records.
RESULTS: The total sample size was 1,700,734 singleton live births. The prevalance of HBV in pregnancy rose from 65.4 per 100,000 births to 123.5 per 100,000 births (p<0.0001 for trend), and the prevalence of HCV in pregnancy increased from 17.0 per 100,000 births to 125.1 per 100,000 births (p<0.0001 for trend). Compared with white mothers, black mothers were more than twice as likely to have HBV in pregnancy (adjusted rate ratios [ARR]=2.24; 95% CI=1.97-2.53). Black mothers were 69% (ARR=0.31, 95% CI=0.25-0.39) and Hispanic mothers were 51% (ARR=0.49, 95% CI=0.41-0.60) less likely to have HCV compared with white mothers.
CONCLUSIONS: Although the overall prevalence rate of HBV increased over the past decade, black women still had a noticeably higher rate of infection. Similarly, white women and those with HIV co-infection had noticeably higher rates of HCV infection over the study period. Our findings call for improved and increased HBV/HCV prevention, screening, and immunization programs among minority women of childbearing age.

Entities:  

Mesh:

Year:  2011        PMID: 22011209     DOI: 10.1089/jwh.2011.2979

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  5 in total

1.  Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program.

Authors:  Kimberly Page; Lawrence Leeman; Steven Bishop; Sandra Cano; Ludmila N Bakhireva
Journal:  Matern Child Health J       Date:  2017-09

2.  Hepatitis C virus infection in mothers and children.

Authors:  Emma Greenaway; Mia J Biondi; Jordan J Feld; Simon C Ling
Journal:  Can Liver J       Date:  2019-12-10

Review 3.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

4.  Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study.

Authors:  Elizabeth E Krans; Susan L Zickmund; Vinod K Rustgi; Seo Young Park; Shannon L Dunn; Eleanor B Schwarz
Journal:  Subst Abus       Date:  2015-11-16       Impact factor: 3.716

5.  Hepatitis C virus infection trends in Italy.

Authors:  Daniel Lavanchy
Journal:  Hepat Mon       Date:  2012-01-20       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.